Shin Junghee J, Liauw Daniel, Siddiqui Sabrina, Lee Juhyeon, Chung Eun Jae, Steele Ryan, Hsu Florence Ida, Price Christina, Kang Insoo
Section of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Yale University School of Medicine, 300 Cedar Street, New Haven, CT, 06520, USA.
J Clin Immunol. 2020 May;40(4):592-601. doi: 10.1007/s10875-020-00773-y. Epub 2020 Apr 2.
Although common variable immunodeficiency (CVID) is considered the most prevalent symptomatic primary antibody deficiency (PAD), there is a population with symptomatic PADs that do not meet criteria for CVID. We analyzed clinical and immunological profiles of patients with different PADs to better understand the differences and similarities between CVID and other PADs.
We extracted clinical and laboratory data of patients with PADs from electronic medical records. Patients were categorized into CVID, IgG subclass 2 deficiency (IgG2D), IgG deficiency (IgGD), and specific antibody deficiency (sAbD) based on basal immunoglobulin levels and pneumococcal vaccine responses. We compared clinical and immunological characteristics in these groups.
All patients, regardless of PAD types, showed similar frequencies of infections, bronchiectasis, and interstitial lung disease (ILD). Hematopoietic malignancies were more frequently found in the CVID than in the IgG2D, IgGD, and sAbD groups, while the latter groups trended towards an increased frequency of connective tissue diseases (CTD). Low counts of natural killer (NK) cells were associated with malignancy, autoimmunity, and ILD in CVID but not in other PAD groups.
Higher frequency of hematopoietic malignancy in CVID than in the other PADs and association of lower NK cell counts with non-infectious complications in CVID suggest a relationship between immune alterations and the development of non-infectious manifestations in PADs.
尽管常见变异型免疫缺陷(CVID)被认为是最常见的有症状的原发性抗体缺陷(PAD),但仍有一部分有症状的PAD患者不符合CVID的标准。我们分析了不同PAD患者的临床和免疫学特征,以更好地了解CVID与其他PAD之间的异同。
我们从电子病历中提取了PAD患者的临床和实验室数据。根据基础免疫球蛋白水平和肺炎球菌疫苗反应,将患者分为CVID、IgG2亚类缺陷(IgG2D)、IgG缺陷(IgGD)和特异性抗体缺陷(sAbD)。我们比较了这些组的临床和免疫学特征。
所有患者,无论PAD类型如何,感染、支气管扩张和间质性肺病(ILD)的发生频率相似。造血系统恶性肿瘤在CVID组中的发生率高于IgG2D、IgGD和sAbD组,而后三组结缔组织病(CTD)的发生率有上升趋势。自然杀伤(NK)细胞计数低与CVID中的恶性肿瘤、自身免疫和ILD相关,但在其他PAD组中无此关联。
CVID中造血系统恶性肿瘤的发生率高于其他PAD,且CVID中较低的NK细胞计数与非感染性并发症相关,这表明免疫改变与PAD中非感染性表现的发生之间存在关联。